U.S. Capital Markets Stock News

Vericel (VCEL) just paired record fourth quarter results with fresh 2026 guidance. This puts its MACI franchise, expanding sales force, and new manufacturing plans in the spotlight for investors watching the stock. See our latest analysis for Vericel. The earnings and 2026 guidance arrived alongside some pressure on the share price, with a 1-day share price return of a 5.31% decline and a 7-day share price return of a 6.33% decline. The 1-year total shareholder return of a 30.43% decline...

Burlington Stores (NYSE:BURL) plans to open 110 net new stores in 2026, ahead of earlier expectations. The company is also expanding its corporate office footprint in New York to support a larger organization. These moves reflect management's intent to scale operations and reinforce Burlington's long term growth plans. Burlington Stores comes into this announcement with its shares at $306.62 and a 1 year return of 23.0%. Over 3 years the stock has returned 41.8%, and over 5 years 9.8%,...

Carvana (CVNA) is back in focus after its latest results showed quarterly and full year revenue and net income figures that were well above the prior year, alongside an updated long term growth plan. See our latest analysis for Carvana. Despite the strong earnings headlines, the share price has been volatile, with a 30 day share price return of 18.35% and a year to date share price decline of 16.35%. At the same time, the 1 year total shareholder return of 43.63% and very large 3 year total...

Asana has launched its AI-powered work management platform in the AWS Middle East (UAE) Region. The company is among the first enterprise collaborative solutions available on AWS Marketplace for this market. The rollout focuses on regulated and public sector customers that require data residency and enterprise-grade security controls. For investors following NYSE:ASAN, this move comes with the stock trading around $7.06 and showing pressure across multiple timeframes, including a 36.5%...

Salesforce (CRM) is back in focus after a busy quarter that combined a Q4 earnings beat, a new US$50b share repurchase authorization, a higher dividend, and fast growing AI driven Agentforce revenue. See our latest analysis for Salesforce. Even with the AI and buyback headlines, Salesforce’s recent share price performance has been weak. The 30-day share price return was 14.95%, and the year-to-date share price return was a 23.56% decline. The 1-year total shareholder return showed a 34.49%...

Apellis Pharmaceuticals (APLS) has drawn fresh attention after reporting fourth quarter and full year 2025 results, showing a move to full year profitability along with a weaker fourth quarter and a more cautious outlook for Syfovre. See our latest analysis for Apellis Pharmaceuticals. The recent earnings release and more cautious commentary around Syfovre seem to have weighed on sentiment, with a 7 day share price return of 6.01% decline and a year to date share price return of 19.03%...

Enviri (NVRI) is back on investors’ radars after recent trading left the shares around $18.93, with returns over the past month, past 3 months, and year showing mixed but meaningful moves. See our latest analysis for Enviri. Recent trading around $18.93 follows a 1 day share price return of 1.83%, while the 90 day share price return of 3.22% sits alongside a very large 1 year total shareholder return of 191.23%. This suggests that momentum has been building over a longer stretch rather than...

Ligand Pharmaceuticals (LGND) has reported FY 2025 results with fourth quarter revenue of US$59.7 million and basic EPS of US$2.27, while trailing twelve month figures show revenue of US$268.1 million and basic EPS of US$6.44. Over the past few quarters, the company has seen revenue move from US$42.8 million in Q4 2024 to US$45.3 million in Q1 2025, US$47.6 million in Q2 2025, US$115.5 million in Q3 2025 and US$59.7 million in Q4 2025, alongside basic EPS ranging from a loss of US$2.21 in Q1...

Recent analysis of Nutex Health’s hybrid model of micro-hospitals, hospital management services, and population health programs highlighted strong profitability metrics and claims of deep undervaluation, drawing fresh investor attention in the past week. An interesting angle is the company’s high free cash flow conversion, which some commentators argue could support a meaningful reassessment of its valuation if operating performance holds. We’ll now examine how Nutex Health’s highlighted...

Centrus Energy has in recent months secured a US$900 million High-Assay Low-Enriched Uranium contract from the U.S. Department of Energy and committed hundreds of millions of dollars to expand its Oak Ridge and Piketon enrichment plants, reinforcing its role in a reshaped Western nuclear fuel supply chain. An important takeaway is that Centrus now sits at the center of a multi‑billion‑dollar backlog through 2040, reflecting how policy shifts away from Russian uranium have turned its unique...

AbCellera Biologics Inc. has reported its full-year 2025 results, with revenue rising to US$75.13 million and net loss easing to US$146.41 million, while also filing a US$45.54 million shelf registration for 15,030,034 common shares tied to an employee share offering. Alongside these financials, AbCellera’s shift into a clinical-stage biotech with advancing programs ABCL635 and ABCL575 and a nearly completed manufacturing facility signals a business model increasingly centered on internal...

International Seaways (INSW) is back in focus after reporting record fourth quarter net income and pairing those results with its largest ever quarterly dividend, a combined US$2.15 per share. See our latest analysis for International Seaways. The latest earnings and dividend news has arrived after a strong run in the shares, with a 30 day share price return of 26.6% and a year to date gain of 60.74%. That move sits on top of a very large 1 year total shareholder return of 143.19% and a 5...

Morgan Stanley and UBS recently upgraded Ermenegildo Zegna Group, following Q4 2025 sales that came in ahead of earlier expectations and highlighted broad-based strength in the core Zegna brand. Analysts pointed to strong engagement from Western affluent consumers across generations as evidence that Zegna’s brand and product positioning are resonating across key demographics. We’ll now examine how this renewed analyst confidence, driven by stronger-than-expected Q4 sales, may influence...

Coursera stock snapshot and recent performance Coursera (COUR) closed at US$6.41, with the share price showing a small gain over the past month but a decline over the past 3 months and past year, including a negative 3 year total return. The company reports annual revenue of US$757.5m and a net loss of US$51.0m. Recent annual figures indicate positive revenue and net income growth, factors some investors watch when assessing an education technology platform. See our latest analysis for...

Arlo Technologies (ARLO) closed out FY 2025 with Q4 revenue of US$141.3 million and basic EPS of US$0.05, alongside net income of US$5.8 million. The trailing 12 month line shows revenue of US$529.3 million and basic EPS of US$0.14 as the business moves further into consistent profitability. Over the past six quarters, the company has seen revenue range from US$119.1 million to US$141.3 million per quarter, with basic EPS shifting from a loss of US$0.05 in late 2024 to positive contributions...

In February 2026, CCC Intelligent Solutions Holdings reported fourth-quarter 2025 revenue of US$277.87 million and net income of US$8.12 million, crossing US$1.06 billion in full‑year sales and issuing 2026 revenue guidance of US$1.15 billion to US$1.16 billion. The results highlighted nearly US$100 million in annual revenue from AI solutions, the EvolutionIQ acquisition to broaden insurance end‑markets, and a new US$500 million share repurchase authorization, including an accelerated US$300...

Helix Energy Solutions Group (HLX) is back in focus after reporting its highest fourth quarter revenue since 2013, positive free cash flow, and year end cash and liquidity that support recently secured multiyear contracts. See our latest analysis for Helix Energy Solutions Group. Those results come after a busy period, with Helix Energy Solutions Group reporting full year 2025 earnings, recording a US$18.06 million long lived asset impairment, completing its share repurchase program, and...

In February 2026, Arcutis Biotherapeutics reported fourth-quarter 2025 revenue of US$129.5 million and full-year revenue of US$376.07 million, moved to a Q4 net profit of US$17.4 million, and raised its 2026 net product revenue guidance to US$480 million–US$495 million while filing an omnibus shelf registration for multiple securities. The results highlight how rapid uptake of ZORYVE across expanded indications, including pediatric use, is beginning to translate into improving profitability...

Corporación América Airports (CAAP) caught investor attention after its January 2026 operating update, with total passenger traffic rising 8.8% year on year. Argentina and Brazil led with record and double digit gains. See our latest analysis for Corporación América Airports. That operating update lands after a mixed few weeks for the share price, with a 1 day share price decline of 1.59% and a 7 day share price decline of 2.56%, but a stronger 90 day share price return of 12.43% and a very...

If you are wondering whether Oddity Tech is now a bargain or a value trap, a closer look at how its current share price lines up with its fundamentals can help frame that question. The stock has seen large price swings recently, with a 7 day return of 63.2% decline, a 30 day return of 64.8% decline, and a year to date return of 70.2% decline, while the 1 year return sits at 75.3% decline from the current last close of US$11.77. These moves have prompted renewed attention on the business, as...

Sabine Royalty Trust (SBR) is in focus after reporting lower royalty and distributable income for 2025, linked to weaker oil prices and production, partly offset by stronger natural gas pricing. See our latest analysis for Sabine Royalty Trust. At a share price of $72.94, Sabine Royalty Trust has recently seen a 7 day share price return of 4.36%. The 90 day share price return shows a decline of 5.76%, which contrasts with a 1 year total shareholder return of 19.65% and a very large 5 year...

If you are wondering whether Barrick Mining is priced attractively today, you are not alone. This article focuses squarely on what the current share price might mean for value‑focused investors. The stock last closed at US$50.76, with returns of 5.8% over 7 days, a 4.2% decline over 30 days, 15.2% year to date, 192.8% over 1 year and 229.7% over 3 years, which can affect how the market currently thinks about its potential and its risks. Recent news around Barrick Mining has highlighted...

Centuri Holdings (NYSE:CTRI) reported record revenue and profitability for 2025. The company secured a 59% increase in backlog to $5.9b, supporting 2026 revenue visibility. Centuri announced expansion into new states and maintained a 100% Master Service Agreement renewal rate. Management is adjusting fleet funding and working to reduce seasonality in its gas business. Centuri Holdings enters 2026 with fresh momentum, backed by record 2025 financial results and a growing project book. The...

If you are wondering whether WEX at around US$149 per share is offering fair value or a potential bargain, you are not alone in questioning what the current price really reflects. Over shorter periods the stock has been under pressure, with a 5.2% decline over the past week, a 3.5% decline over 30 days, a 5.0% decline over 1 year and a 30.3% decline over 5 years, while the year-to-date return sits at 0.5%. These moves have come as investors continue to reassess payment and fintech related...